Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Docetaxel vs AC vs Alternating AC-Docetaxel in Metastatic Breast Cancer
NCT00190489Phase 3Completed
- Sponsor
- Japan Clinical Oncology Group
- Start
- Jan 1999
- Primary completion
- May 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of docetaxel in breast cancer, sponsored by Japan Clinical Oncology Group. Started Jan 1999; status: completed.
02
Drugs
docetaxel
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT00190489.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00190489.